Marksans Pharma bags FDA approval for Mucinex bioequivalent tablets
Indian pharmaceutical powerhouse, Marksans Pharma has achieved a significant milestone, securing the coveted US Food and Drug Administration (FDA) nod for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets in both 600 mg and 1200 mg concentrations. These breakthrough tablets are confirmed to be bioequivalent to the acclaimed Mucinex Extended-Release Tablets of the […]